176 related articles for article (PubMed ID: 2147600)
1. The interaction between clonidine and growth hormone releasing hormone in the stimulation of growth hormone secretion in man.
Suri D; Hindmarsh PC; Brain CE; Pringle PJ; Brook CG
Clin Endocrinol (Oxf); 1990 Sep; 33(3):399-406. PubMed ID: 2147600
[TBL] [Abstract][Full Text] [Related]
2. Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
Massoud AF; Hindmarsh PC; Brook CG
Clin Endocrinol (Oxf); 1997 Nov; 47(5):537-47. PubMed ID: 9425393
[TBL] [Abstract][Full Text] [Related]
3. The inhibitory effects of growth hormone-releasing hormone (GHRH)-antagonist on GHRH, L-dopa, and clonidine-induced GH secretion in normal subjects.
Hanew K; Tanaka A; Utsumi A; Sugawara A; Abe K
J Clin Endocrinol Metab; 1996 May; 81(5):1952-5. PubMed ID: 8626863
[TBL] [Abstract][Full Text] [Related]
4. The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.
Massoud AF; Hindmarsh PC; Matthews DR; Brook CG
Clin Endocrinol (Oxf); 1996 May; 44(5):555-62. PubMed ID: 8762732
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone releasing hormone 1-44 NH2 and 1-40 OH levels in normal subjects during growth hormone stimulation tests.
Page MD; Dieguez C; Valcavi R; Koppeschaar HP; Scanlon MF
Clin Endocrinol (Oxf); 1994 Jan; 40(1):97-102. PubMed ID: 8306488
[TBL] [Abstract][Full Text] [Related]
6. Effects of intranasal calcitonin administration on pituitary GH response to hGHRH (1-29)NH2 in normal adult subjects.
Giustina A; Romanelli G; Doga M; Pizzocolo G; Giustina G
Clin Endocrinol (Oxf); 1989 Jun; 30(6):699-704. PubMed ID: 2556224
[TBL] [Abstract][Full Text] [Related]
7. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
Devesa J; Diaz MJ; Tresguerres JA; Arce V; Lima L
J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
[TBL] [Abstract][Full Text] [Related]
8. Direct effects of corticotrophin-releasing hormone on stimulated growth hormone secretion.
Raza J; Massoud AF; Hindmarsh PC; Robinson IC; Brook CG
Clin Endocrinol (Oxf); 1998 Feb; 48(2):217-22. PubMed ID: 9579235
[TBL] [Abstract][Full Text] [Related]
9. Interaction of clonidine and GHRH on GH secretion in vivo and in vitro.
Alba-Roth J; Losa M; Spiess Y; Schopohl J; Müller OA; von Werder K
Clin Endocrinol (Oxf); 1989 May; 30(5):485-91. PubMed ID: 2514051
[TBL] [Abstract][Full Text] [Related]
10. Effects of calcitonin on GH response to pyridostigmine in combination with hGHRH (1-29) NH2 in normal adult subjects.
Giustina A; Bodini C; Bossoni S; Doga M; Girelli A; Pizzocolo G; Wehrenberg WB
Clin Endocrinol (Oxf); 1990 Sep; 33(3):375-80. PubMed ID: 2147598
[TBL] [Abstract][Full Text] [Related]
11. Combined administration of growth-hormone-releasing hormone and clonidine restores defective growth hormone secretion in old dogs.
Cella SG; Arce VM; Pieretti F; Locatelli V; Settembrini BP; Müller EE
Neuroendocrinology; 1993 Mar; 57(3):432-8. PubMed ID: 8321415
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone responses to growth hormone-releasing hormone (1-29)-NH2 and a D-Ala2 analog in normal men.
Barron JL; Coy DH; Millar RP
Peptides; 1985; 6(3):575-7. PubMed ID: 2866496
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
Díez J; Iglesias P; Sastre J; Méndez J; Selgas R; Gómez-Pan A
Nephron; 1996; 74(3):548-54. PubMed ID: 8938679
[TBL] [Abstract][Full Text] [Related]
14. The interaction of growth hormone releasing hormone and somatostatin in the generation of a GH pulse in man.
Hindmarsh PC; Brain CE; Robinson IC; Matthews DR; Brook CG
Clin Endocrinol (Oxf); 1991 Oct; 35(4):353-60. PubMed ID: 1684314
[TBL] [Abstract][Full Text] [Related]
15. Responses to analogues of growth hormone-releasing hormone in normal subjects, and in growth-hormone deficient children and young adults.
Grossman A; Savage MO; Lytras N; Preece MA; Sueiras-Diaz J; Coy DH; Rees LH; Besser GM
Clin Endocrinol (Oxf); 1984 Sep; 21(3):321-30. PubMed ID: 6236914
[TBL] [Abstract][Full Text] [Related]
16. Physiological levels of growth hormone fail to suppress growth hormone releasing hormone (1-29) NH2-stimulated growth hormone secretion in man.
Brain C; Thakrar DN; Hindmarsh PC; Brook CG
J Endocrinol Invest; 1993 Jan; 16(1):15-20. PubMed ID: 8445152
[TBL] [Abstract][Full Text] [Related]
17. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
Devesa J; Arce V; Lois N; Tresguerres JA; Lima L
J Clin Endocrinol Metab; 1990 Dec; 71(6):1581-8. PubMed ID: 1977761
[TBL] [Abstract][Full Text] [Related]
18. The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man.
Micic D; Popovic V; Kendereski A; Peino R; Dieguez C; Casanueva FF
Clin Endocrinol (Oxf); 1996 Nov; 45(5):543-51. PubMed ID: 8977750
[TBL] [Abstract][Full Text] [Related]
19. Radiation and neuroregulatory control of growth hormone secretion.
Ogilvy-Stuart AL; Wallace WH; Shalet SM
Clin Endocrinol (Oxf); 1994 Aug; 41(2):163-8. PubMed ID: 7923820
[TBL] [Abstract][Full Text] [Related]
20. GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: studies with pyridostigmine and GHRH.
Ross RJ; Tsagarakis S; Grossman A; Nhagafoong L; Touzel RJ; Rees LH; Besser GM
Clin Endocrinol (Oxf); 1987 Dec; 27(6):727-33. PubMed ID: 2901302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
